Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30

$9.86+0.08 (+0.82%)

Close on Nov 13, 2026Market cap $370.94MP/E –Yield –

Contineum Therapeutics statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 4, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $370.94M; $272.32M
Enterprise Value: $134.34M; $146.23M
PB Ratio: 1.55; 2.00
P/TBV Ratio: 1.55; 2.22

Share statisticsIndustry

Shares Outstanding: 38M; 58M
Shares Change (YoY): 29.5%; 10.8%
Float: 37M; 49M
Shares Held by Insiders: 0.50%; 11.7%
Shares Held by Institutions: 81.2%; 56.4%

Short sellingIndustry

Short Interest: 4M; –
Short Interest Change: 1.13%; -0.80%
Short % of Float: 9.88%; 9.01%
Short % of Shares Outstanding: 9.83%; 6.30%
Days to Cover: 4.23; 5.15

Stock price statisticsIndustry

52-Week High: $17.79; –
52-Week Low: $6.72; –
20-Day Moving Average: $9.23; –
50-Day Moving Average: $11.28; –
200-Day Moving Average: $13.40; –
Average True Range (14): $0.89; –
Price Change (1 Week): 3.57%; -1.15%
Price Change (1 Month): 24.8%; -4.87%
Price Change (3 Months): -32.1%; -21.0%
Price Change (6 Months): -28.1%; -20.6%
Price Change (YTD): -13.7%; -23.6%
Price Change (1 Year): -14.0%; -22.4%
Average Volume (10 Days): 401,016; –
Average Volume (20 Days): 634,712; –
Average Volume (90 Days): 676,939; –
Relative Volume: 0.39; 0.70
Relative Strength Index (14): 48.3; 43.4
Volatility (1 Year): 80.6%; 80.1%
Beta (5 Years): 0.67; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -28.0%; -49.9%
Return on Assets (ROA): -26.6%; -40.6%
Return on Capital Employed (ROCE): -27.2%; -37.9%

Financial positionIndustry

Current Ratio: 37.17; 3.30
Quick Ratio: 36.26; 2.39

EfficiencyIndustry

Profits Per Employee: -$1.13M; -$689.41K
Employee Count: 51; 74
WACC: 8.43%; 10.2%

Income statement (TTM)Industry

Operating Income: -$66.38M; -$21.37M
Net Income: -$57.56M; -$22.35M
EBITDA: -$66.00M; -$17.21M
EPS (Diluted): -$1.73; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $236.60M; $68.68M
Net Cash (Debt): $236.60M; $17.76M
Net Cash Per Share: $6.29; $0.80
Equity (Book Value): $239.66M; $53.89M
Book Value Per Share: $6.37; $1.50
Tangible Book Value: $239.66M; $27.13M
Working Capital: $236.05M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$53.01M; -$12.38M
Capital Expenditures: -$458.00K; -$1.00M
Free Cash Flow: -$53.46M; -$18.21M
FCF Per Share: -$1.42; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -15.5%; -21.8%
FCF Yield: -14.4%; -9.44%

Scores and fair valueIndustry

Altman Z-Score: 19.89; 0.23
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	CTNM	S&P 500	Difference
1 month	+17.1%	-3.0%	+20.1 pts
3 months	-35.6%	-2.8%	−32.8 pts
Year to date	-13.7%	+11.5%	−25.2 pts
1 year	-9.5%	+13.5%	−23.0 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

4M CTNM shares were sold short on Oct 30, 2026, up 1.1% from the previous report, or 9.88% of the shares available to trade. At recent volumes it would take 4.2 days to buy them back. Over the last 20 sessions, 50.9% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	3,696,673	+1.1%	874,802	4.2
Oct 15, 2026	3,655,234	+19.2%	1,638,090	2.2
Sep 30, 2026	3,067,588	+25.5%	847,470	3.6
Sep 15, 2026	2,443,708	+4.4%	352,131	6.9
Aug 31, 2026	2,340,890	+0.2%	582,694	4.0
Aug 14, 2026	2,336,664	-17.2%	524,037	4.5
Jul 31, 2026	2,822,177	+15.5%	208,549	13.5
Jul 15, 2026	2,443,643	+14.3%	333,697	7.3
Jun 30, 2026	2,137,692	+29.2%	720,371	3.0
Jun 15, 2026	1,654,976	+15.6%	217,886	7.6
May 29, 2026	1,431,603	+1.0%	152,955	9.4
May 15, 2026	1,417,410	-11.7%	210,249	6.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?